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PED/PEA-15 is a death effector domain (DED) family member with a variety of effects on cell growth andmetabolism. To get further insight
into the role of PED in cancer, we aimed to ﬁnd new PED interactors. Using tandem afﬁnity puriﬁcation, we identiﬁed HSC70 (Heat Shock
Cognate Protein of 70 kDa)—which, among other processes, is involved in chaperone-mediated autophagy (CMA)—as a PED-interacting
protein.We found that PED has twoCMA-like motifs (i.e., KFERQ), one of which is located within a phosphorylation site, and demonstrate
that PED is a bona ﬁde CMA substrate and the ﬁrst example in which phosphorylation modiﬁes the ability of HSC70 to access KFERQ-like
motifs and target the protein for lysosomal degradation. Phosphorylation of PED switches its function from tumor suppression to tumor
promotion, and we show that HSC70 preferentially targets the unphosphorylated form of PED to CMA. Therefore, we propose that the
up-regulated CMA activity characteristic of most types of cancer cell enhances oncogenesis by shifting the balance of PED function toward
tumor promotion. This mechanism is consistent with the notion of a therapeutic potential for targeting CMA in cancer, as inhibition of this
autophagic pathway may help restore a physiological ratio of PED forms.
J. Cell. Physiol. 229: 1359–1368, 2014. © 2014 Wiley Periodicals, Inc.
Phosphoprotein enriched in diabetes (PED), known also as
phosphoprotein enriched in astrocytes 15 (PEA-15), is a death
effector domain (DED) family member with a variety of effects
on cell growth andmetabolism (Condorelli et al., 1999; Renault
et al., 2003). It has a broad anti-apoptotic action, being able to
inhibit the intrinsic and the extrinsic apoptotic pathways
(Stassi et al., 2005; Garofalo et al., 2008; Zanca et al., 2008;
Incoronato et al., 2010). PED is known to interact with a
number of proteins, among which are extracellular signal-
regulated protein kinases 1 and 2 (ERK1/2), sequestering them
in the cytosol and, thus, regulating their function (Formstecher
et al., 2001; Romano et al., 2012). PED can be found in an
unphosphorylated state, or phosphorylated at Ser104 by
protein kinase C, and at Ser116 by AKT or calcium calmodulin
kinase II (CamKII) (Trencia et al., 2003; Sulzmaier et al., 2012).
Interestingly, PED can act as either a tumor promoter (when
phosphorylated) or a tumor suppressor (when unphosphory-
lated) (Sulzmaier et al., 2012). Moreover, PED has been
reported up-regulated in a number of different cancer types,
but the mechanisms regulating its expression remain poorly
understood (Hao et al., 2001; Stassi et al., 2005; Garofalo
et al., 2007; Zanca et al., 2008).
To get further insight into the role of PED in cancer, we have
previously reported on the PED interactome identiﬁed
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through tandem afﬁnity puriﬁcation (TAP) in non-small-cell
lung-cancer cells (Zanca et al., 2010): among the interacting
proteins found were RAC1 (ras-related C3 botulinum toxin
substrate 1), a mammalian rho GTPase protein family member,
and HSC70 (heat shock cognate protein of 70 kDa), a
chaperone involved in a multitude of housekeeping functions
and in chaperone-mediated autophagy (CMA) (Kaushik and
Cuervo, 2012a,b). CMA is a uniquely selective form of
autophagy in which speciﬁc cytosolic proteins are transported
one-by-one across the lysosomal membrane for degradation
(Massey et al., 2006). This process is constitutively active in
many cell types, but it is maximally activated during stress
(Kaushik and Cuervo, 2012a). CMA is selective for a subset of
soluble cytosolic proteins containing a pentapeptide motif—
known as the CMA-targeting motif—biochemically related to
Lys-Phe-Glu-Arg-Gln (KFERQ) (Dice, 1990). In the cytosol,
HSC70 recognizes the KFERQ sequence present in CMA
substrates, and chaperones them to the lysosomal membrane,
where they can interact with lysosome-associated protein type
2A (LAMP2A), the CMA receptor. Moreover, HSC70 likely
facilitates substrate unfolding, a requirement for substrate
translocation across the lysosomal membrane (Kaushik and
Cuervo, 2012a,b).
In the present report, we describe the interaction of PED
with HSC70, demonstrating that HSC70 targets
unphosphorylated PED for CMA. This event has a deleterious
effect on cell fate by promoting tumorgenesis.
Materials and Methods
Cell lines and reagents
The human A549 cell line was purchased from American Type
Culture Collection (Milan, Italy) and maintained in RPMI medium
supplemented with 10% heat-inactivated fetal bovine serum (FBS),
2mM L-glutamine, and 100U/ml penicillin–streptomycin. The
human embryonic kidney (HEK) 293 cell line was grown in DMEM
supplemented with 10% heat-inactivated FBS, 2mM L-glutamine,
and 100U/ml penicillin–streptomycin. Media, sera, and antibiotics
for cell culture were from Sigma–Aldrich (Milan, Italy). Protein
electrophoresis reagents were from Bio-Rad (Milan, Italy), and
Western blotting and ECL reagents were from GE Healthcare
(Milan, Italy). HSC70 antibody was from Santa Cruz Biotechnology
(Santa Cruz, CA), human LAMP2A antibodywas fromAbcam (MA),
b-actin antibody was from Sigma–Aldrich, and Myc antibody was
fromCell Signaling Technology (Milan, Italy). The PED antibody was
generated as described before (Condorelli et al., 2002). For
transfection, Lipofectamine 2000 was purchased from Life
Technologies (Milan, Italy). The plasmids used encoded Myc–PED
(Condorelli et al., 1998) and the phosphorylationmutantsHA-PED-
S104/116A and HA-PED-S104/116D (a kind gift from Dr Mark H.
Ginsberg, The Scripps Research Institute, La Jolla, San Diego, CA);
Lamp2a shRNA and Lamp2a cDNA were from Dr Ana Maria
Cuervo (Massey et al., 2006);) siRNA for Hsc70 was from Santa
Cruz Biotechnology. Cloroquine and NH4Cl were from Sigma–
Aldrich. All the chemicals used for the in vitro lysosome
experiments have been described previously (Cuervo et al., 1994).
Immunoprecipitation
HEK293 cells were cultured at 90% ﬁnal conﬂuence in p100 plates.
After 24 h, cells were transfected with 8mg of plasmids using
Lipofectamine 2000. Forty-eight hours later, the cells were
harvested with RIPA buffer (0.15mMNaCl, 0.05mMTris–HCl, pH
7.5, 1% Triton, 0.1% SDS, 0.1% sodium deoxycolate, 1% Nonidet
P40, and 1 protease and phosphatase inhibitor cocktail) on a
shaker for 30min, and 1mg of total extract immunoprecipitated
with 4mg/ml PED antibody or a 1:1,000 dilution of Myc antibody
for 16 h on a shaker. A/G beads (Santa Cruz Biotechnology) were
then added for 2 h, after which the beads were washed three times
with washing buffer (50mM Tris–HCl pH 7.5, 150mM NaCl, 0.1%
Triton, 10% glycerol), 30ml of sample buffer added, and the
samples boiled at 100°C for 5min. The supernatants were
resolved on 12% polyacrylamide gels by SDS–PAGE.
Western blotting
Total proteins from A549 and HEK293 cells were extracted with
RIPA buffer. Fifty micrograms of sample extract were resolved on
10–15% SDS–polyacrylamide gels using a mini-gel apparatus
(Bio-Rad Laboratories, Richmond, CA) and transferred to
Hybond-C extra nitrocellulose (GE Healthcare, Milan, Italy).
Membranes were blocked for 1 h with 5% non-fat dry milk in
TBS–0.05% Tween-20, incubated overnight with primary antibody,
washed, incubated for 1 h with secondary antibody, and visualized
by chemiluminescence.
Immunoﬂuorescence
A549 cells were serum starved for 24 h before analysis. To
enhance the lysosomal localization and to prevent degradation,
baﬁlomycin A (Sigma–Aldrich) was added to serum-depleted
media. Cells were ﬁxed with 4% paraformaldehyde for 10min,
permeabilized with Triton 0.1% in PBS for 10min at room
temperature, and blocked in 10% FBS–0.1 % saponin in PBS.
Primary antibodies were dissolved in 1:10-diluted blocking
solution and incubated at the following dilutions for 1 h at room
temperature: anti-PED, 1:100; anti-HSC70, 1:100; anti-LAMP2A,
1:200. Cells were then incubated for 1 h at room temperature as
appropriate with an anti-rabbit green ﬂuorochrome antibody
(Alexa 488-conjugated phalloidin), an anti-rabbit red
ﬂuorochrome antibody (Alexa 594), or an anti-mouse red
ﬂuorochrome antibody (Alexa 459), all purchased from BD
Bioscience (Milan, Italy) and diluted 1:1,000 in 1:10-diluted blocking
solution. Cells were then washed four times in cold PBS. Antigen–
antibody complexes were visualized by confocal microscopy under
a Zeiss LSM 510 microscope equipped with a Zeiss confocal-
scanning laser and a 1.4 objective with a 60 numerical aperture.
Quantiﬁcation of cell viability
Cells were seeded in 96-well plates in triplicate and incubated at
37°C in a 5% CO2 incubator. SuperKiller TRAIL was used at a ﬁnal
concentration of 50 ng/ml for 24 h. Cell viability was evaluated with
the CellTiter 96 AQueous One Solution Cell Proliferation Assay
(Promega, Milan, Italy), according to the manufacturer’s protocol.
Metabolically active cells were detected by adding 20ml of MTS to
each well. After 2 h of incubation, plates were analyzed in a
Multilabel Counter (BioTek, Milan, Italy).
Recombinant PED protein production
BL21 cells were transformed with a glutathione-S-transferase
(GST)–PED vector. The cells were induced with 0.5mM IPTG
(Qiagen, Milan, Italy) for 4 h, harvested, resuspended in PBS, and
then sonicated. 1% Triton X-100 was added at a ﬁnal
concentration of 0.1% and the cells were left for 30min in agitation
on a wheel at 4°C. Lysates were then centrifuged at 12,000g for
10min at 4°C and then loaded onto a polyacrylamide analytic gel.
GST-tagged protein was isolated using GSTrap HP columns (GE
Healthcare, Milan, Italy) according to manufacturer’s instructions.
Brieﬂy, columns were equilibrated with cold 1 PBS, and lysate
pumped onto the columns. After ﬁvewashings with 1 PBS, tagged
protein was eluted with 1ml elution buffer (50mM Tris-HCl,
10mM reduced glutathione, pH 8.0). Eluted protein was aliquoted
and stored at80°C. The puriﬁed GST–PED recombinant protein
was analyzed by staining of SDS–PAGE gels with Sypro-Ruby
protein gel stain (Life Technologies, Milan, Italy). We observed a
37 kDa band relative to puriﬁed GST-PED recombinant protein
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and an aspeciﬁc lower second band that remains constant and
therefore not related to PED expression (Supplementary Fig. 1A).
GST pull-down assay
Cells were cultured at a ﬁnal concentration of 90% in p100 plates.
After a quickwashwith ice-cold PBS, cellswere lysedwithGST–Fish
buffer (50mM Tris–HCl pH 7.4, 2mM MgCl2, 1% NP-40, 10%
glycerol, 100mM NaCl, 1mg/ml leupeptin, 1mg/ml pepstatin,
1mg/ml aprotinin, 1mM PMSF, and 2mM DTT). The lysates were
cleared by centrifugation in a pre-cooled rotor. One hundred ﬁfty
micrograms of total protein extract was mixed with 10 or 20mg of
GST–PED recombinant protein coupled to glutathione–sepharose
beads and incubated 30min at 4°C with agitation. Beads were then
rapidly rinsed three times with 1ml of ice-cold GST–Fish buffer
(Zanca et al., 2010). TotalHSC70was estimated by immunoblotting.
Animals
Adult maleWistar rats (Charles River Laboratories, Milan, Italy) with
a body weight of 200–250 g were fasted for 48 h before sacriﬁce and
removal of livers. Rats were treated and euthanized in compliance
with the Albert Einstein College of Medicine institutional guidelines
and protocols. Approval for the experimentation was received from
the institution’s Animal Care and Use Committee.
Lysosomal isolation
The method used has been described previously (Cuervo
et al., 1997). Brieﬂy, fastedWistar ratswere anesthetizedwith ether
and then decapitated. Liver homogenates were centrifuged at
2,500g for 10min on 7ml chilled 0.25M sucrose/g of tissue, and then
the supernatant centrifugedat 6,800g for 25min.After resuspension
andwashing once, the sediment (mitochondrial–lysosomal fraction)
was loaded on the bottom of a discontinuous metrizamide gradient
(Nycomed,Oslo,Norway) and centrifuged for 2 h. Fractions 1 and 2
were collected from the gradient, diluted ﬁve times with 0.3M
sucrose, and lysosomes sedimented at 37,000g for 10min.
Lysosomal integrity was veriﬁed after isolation by measuring
b-hexosaminidase latency (Storrie and Madden, 1990), and only
preparations with >95% intact lysosomes were used.
Measurement of CMA activity
Freshly isolated rat liver lysosomes that had been either left
untreated or treated with protease inhibitors for 10min at 0°C
were incubated with recombinant PED, ovalbumin, or
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in 10mM
3-(N-morpholino) propanesulfonic acid (MOPS) buffer (pH 7.3)
and 0.3M sucrose for 20min at 37°C (Kaushik and Cuervo, 2009).
Lysosomes were then collected by centrifugation, subjected to
Fig. 1. Validation of PED–HSC70 interaction. A,B: Representative immunoprecipitation experiments on HEK293 cells transfected with
Myc–PED cDNA. After 48h, 1mg of protein extracts were immunoprecipitated with anti-PED (A), anti-HSC70 (B), or control IgG, as
indicated. C: Representative GST pull-down experiment. A549 cell extracts were incubated with two amounts of glutathione–sepharose 4B
beads pre-bound to GST–PED fusion protein. The negative control was obtained by incubating cellular extracts with beads not pre-bound to
GST–PED; pre-bound GST–PED fusion beads (10mg) were used as the positive control. Fifty micrograms of total cellular extract was loaded.
D: representative confocal experiments. The distribution of PED and HSC70 in A549 cells was determined with confocal microscopy. The
intensity of the yellow immunofluorescence signal represents the degree of co-localization of the two proteins. We observed an 18.5% overlay
of the two signals.
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SDS–PAGE, and immunoblotted. Uptake was calculated as the
difference between the amount of substrate associated with
lysosomes (protease inhibitor-treated lysosomes) and the amount
of substrate bound to their membrane (untreated lysosomes).
Statistical analysis
Student’s t-test was used to analyze the differences between
values. A probability level <0.05 was considered signiﬁcant. Data
were analyzed with GraphPad Prism for Windows (San Diego,
CA). Quantiﬁcation was obtained with ImageJ for Windows
(http://rsb.info.nih.gov). Immunoﬂuorescence co-localization
signals were obtained with ImageJ plugins, considering 35 cells/
image of three different acquisitions.
Results
PED interacts with HSC70
Using TAP (Zanca et al., 2010), we identiﬁed an interaction
between HSC70 and PED. That ﬁnding was conﬁrmed by three
other approaches (Fig. 1): co-immunoprecipitation, GST
fusion protein pull-down, and confocal microscopy. For the
co-immunoprecipitation experiment, A549 cells—an
adenocarcinomic human alveolar basal epithelial cell line—
were transfected with Myc–PED cDNA, the cell extract
immunoprecipitated with anti-PED, and the interaction
revealed by Western blotting with anti-HSC70 (Fig. 1A); in
addition, some samples were immunoprecipitated with anti-
HSC70 and then blotted forMyc (Fig. 1B). In both experimental
settings, HSC70 co-immunoprecipitated with PED. We then
assessed the direct binding of PED with HSC70 in A549 cell
extracts incubated with different quantities of a recombinant
GST–PED fusion protein or, as a negative control, with
glutathione–sepharose 4B beads not pre-bound to the
recombinant protein. We found that HSC70 was pulled down
by the GST-PED recombinant protein in a dose-dependent
manner (Fig. 1C). Finally, we observed clear PED–HSC70 co-
localization with confocal microscopy: co-localization of the
immunoﬂuorescence signals occurred mostly in the cytosol,
although it was also present in punctate structures suggestive
of intracellular vesicles (Fig. 1D).
PED–HSC70 interaction and CMA
Next, we assessed whether PED’s association with HSC70 was
at least in part due to its targeting for CMA. For this purpose,
Fig. 2. PED localizes to CMA-associated lysosomes. A: Cellular localization of PED (green) and LAMP2A (red) in A549 cells cultured with (þ) or
without () serum. DAPI was used to stain nuclei. The graph on the right gives relative quantitative analysis of PED/LAMP2A co-localization.
Serum starvation, which enhances CMA, was associated with increased signal co-localization, indicative of PED localizing to CMA-associated
lysosomes. Means þ standard deviations; statistical analysis is Student’s t-test. B: Cellular localization of PED (green) and HSC70 (red) in A549
cells cultured with and without serum. The graph on the right gives relative quantitative analysis of PED/HSC70 co-localization. Again, signal
co-localization was increased in serum-starved cells. Meansþ standard deviations; statistical analysis is Student’s t-test.
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A549 cells were cultured either in the presence of serum, a
condition resulting in low CMA, or with prolonged (24 h)
serum starvation, a setting in which CMA is enhanced (Cuervo
et al., 1997), we evaluated the intracellular distribution of PED
and its co-localization with HSC70- and LAMP2A-positive
lysosomes with confocal microscopy. As expected, serum
starvation up-regulated CMA, with CMA-associated lyso-
somes, that is, those enriched in LAMP2A (Supplementary
Fig. 2A) and HSC70 (Supplementary Fig. 2B), clearly relocating
to the perinuclear region (Kaushik and Cuervo, 2009), and with
the co-localization of HSC70 and LAMP2A signiﬁcantly
increasing within vesicular structures (Supplementary Fig. 2B).
PED also co-localized with LAMP2A (Fig. 2A) and HSC70
(Fig. 2B), especially when CMA activity was stimulated by
serum starvation.
Uptake of PED in ex vivo lysosomes
The most direct way to determine if a protein is a CMA
substrate is to reproduce its direct translocation into isolated
lysosomes (Cuervo et al., 1997; Kaushik and Cuervo, 2009).
Therefore, we incubated intact ex vivo rat liver lysosomes with
puriﬁed recombinant GST–PED protein and determined
lysosomal uptake by comparing the amounts of PED associated
with lysosomes previously treated or not with protease
inhibitors.We found that a fraction of PEDwas associated with
lysosomes and that the amount increased with protease
inhibition, conﬁrming that PED accumulates within lysosomes
(Fig. 3A,B). The same behavior was observed for other well-
characterized CMA substrates, like ribonuclease A, GAPDH
(Cuervo et al., 1994), and tau protein, but was not observed for
cyclophilin A, which is not a substrate for CMA (Fig. 3A). The
accumulation of PED in lysosomes was saturable (Fig. 3C).
To further conﬁrm that internalization of PED within
lysosomes was due to CMA, we compared the effect that other
proteins had on PED uptake. Ovalbumin—a protein lacking any
KFERQ-like motif and reported not to undergo CMA (Cuervo
et al., 1994)did not have any effect on the amount of PED
associated with lysosomes; in contrast, GAPDH was able to
partially reduce PED uptake, indicating competition for
components of the CMAmachinery (Fig. 3D). This competition
between PED and other CMA degradable proteins was
reciprocal, since increasing concentrations of one gradually
decreased the amount associated with lysosomes of the other
(Fig. 3E). These ﬁndings support the notion that PED is a bona
ﬁde CMA substrate, since it can be internalized directly into
Fig. 3. Uptake of PED by lysosomes via chaperone-mediated autophagy. A: Intact ex vivo rat liver lysosomes were pretreated (þ) or not ()
with protease inhibitors (PI) and then incubated with either purified GST–PED, a known CMA substrate (i.e., ribonuclease A: RNase;
glyceraldehyde 3 phosphate dehydrogenase: GAPDH; tau protein: Tau), or a non-CMA substrate protein (cyclophillyn A: CycA). Lysosomes
were collected by centrifugation and subjected to SDS–PAGE and immunoblotting. In: input. B: Quantification of the association of PED with
lysosomes. Values are expressed as a percentage of the protein added (0.1mg), calculated as described in the Material and Methods section.
Means þ standard errors of n¼ 4 experiments. C: Lysosomes were incubated with increasing amounts of GST–PED and processed as in (A).
Representative immunoblot (left) and quantification of the percentage of PED accumulated within lysosomes (right). In: input; þ and
: respectively, lysosomes incubated with and without protease inhibitors. D: Lysosomes that had been pretreated (þ) or not () with
protease inhibitors were incubated with PED in the presence of GAPDH or ovalbumin (OVA), respectively a CMA and a non-CMA substrate,
and processed as in (A). Representative immunoblot (top). Quantification (bottom) indicated that lysosomal uptake of PED was reduced 38%
in the presence of GAPDH. Values are meansþ standard errors of n¼ 4 experiments. E: Lysosomes were incubated with a fix concentration of
PED and then increasing concentrations of RNase A (left) or with a fixed amount of RNase A and then increasing concentrations of PED
(right). As can be seen from the representative immunoblots, competition for lysosomal uptake was reciprocal.
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isolated lysosomes using similar mechanisms to those
described for other CMA-degraded proteins (Cuervo
et al., 1994; Salvador et al., 2000).
PED level is regulated by lysosomal activity
We then tested whether the modulation of lysosome activity in
intact cells could affect the intracellular levels of PED. To this
end, CMA was activated or inhibited in A549 cells and
intracellular PED levels then assessed. To activate CMA, cells
were incubated in serum-deprived medium or transfected with
LAMP2A cDNA, the protein limiting CMA (Cuervo and
Dice, 2000). In both settings, the intracellular level of PED
decreased (Fig. 4A). Coherently, when CMAwas inhibited with
chloroquine—an inhibitor of lysosome-mediated degradation
for all types of autophagy—or with Lamp2a shRNA or HSC70
RNAi, intracellular PED increased (Fig. 4B). Moreover,
induction/inhibition of CMA modulated the level of exogenous
PED (Fig. 4C). Thus, a part of cellular PED normally undergoes
degradation in lysosomes via CMA.
Role of phosphorylation in CMA-mediated PED
degradation
The KFERQmotif consists of a glutamine preceded or followed
by a basic (lysine/arginine; represented with a þ), an acidic
(aspartic acid/glutamic acid; represented with a ), a bulky
hydrophobic (phenylalanine/isoleucine/leucine/valine;
represented with w), and then a repeated basic or bulky
hydrophobic amino acid. A small number of peptides will have
the glutamine substituted by the related amino acid asparagine
(Dice, 1990; Majeski and Fred Dice, 2004). The analysis of
PED’s amino acid sequence revealed the presence of two
possible CMA-targeting motifs: NKLDK (amino acids 52–57;
Nþwþ), and DIIRQ (amino acids 110–115; wwþQ)
(Fig. 5A). The latter motif resides close to two major PED
Fig. 4. PED expression is affected by CMA activity. A: CMA was activated in A549 cells by either 12 or 24h of serum starvation (top panel) or
by transfection with Lamp2a cDNA (bottom panel). Incubation with serum or an empty vector were used as controls. Western blotting
revealed that the intracellular level of PED decreased when CMA was activated. Representative blots are shown. The numbers in brackets
indicate optical density of the bands, arbitrarily set to 1 for the negative control lysate. B: Inhibition of CMA with increasing doses of
chloroqiuine (CQ), a lysosomal inhibitor (top-most panel), increased intracellular PED, as did intervention on the CMA-associated proteins
LAMP2A (middle panel) and HSC70 (bottom-most panel) with short hairpin RNA (shRNA) and RNA interference (RNAi). Scrambled
sequences (Scr) were used for control experiments. The numbers in brackets indicate optical density of the bands, arbitrarily set to 1 for the
negative control lysate. C: A549 cells were transfected for 24h with MycPED cDNA and then serum deprived or treated with 10mM
chloroquine (CQ) for 24h or 15mM ammonium chloride (NH4Cl) for 4 h. PED levels were then assessed by Western blot. The numbers in
brackets indicate optical density of the bands, arbitrarily set to 1 for the PED-Myc lysate.
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phosphorylation sites — Ser114 and Ser116 (Condorelli
et al., 2002; Trencia et al., 2003; Stassi et al., 2005). Therefore,
we tested whether PED phosphorylation affected its interac-
tion with HSC70 and, hence, its degradation via CMA. For this
purpose, we transfected HEK293 cells with either a phos-
phomimic PED mutant in which Ser104/116 were substituted
with aspartic acids (HA-PED-S104/116D), or with a phos-
phorylation-dead mutant in which Ser104/116 were substi-
tuted with alanines (HA-PED-S104/116A) (Krueger et al., 2005;
Sulzmaier et al., 2012). We found that PED-S104/116A
interacted with HSC70 almost twofold more than did PED-
S104/116D (Fig. 5B). Therefore, changes in PED phosphory-
lation state modify its amenability for lysosomal degradation.
Coherently, when lysosomal degradation was inhibited with
either NH4Cl or chloroquine, wild-type PED and PED-S104/
116A accumulated, whereas PED-S104/116D levels remained
unchanged (Fig. 5C).
To prove that the ﬁndings were related to CMA, we induced
CMA with either serum starvation or overexpression of
LAMP2A with a cDNA. We found that up-regulation of CMA
resulted in a more pronounced decrease in the level of PED-
S104/116A than of wild-type PED, indicative of increased
degradation of PEDwhen unphosphorylated; in contrast, levels
of PED-S104/116D remained unchanged upon CMA up-
regulation (Fig. 5D), consistent with a failure to undergo
degradation via this pathway when PED is phosphorylated.
Physiological relevance of CMA for PED function
The main activity of PED, in non-small-cell lung carcinoma
above all, is the regulation of cell apoptosis/viability (Condorelli
et al., 1999, 2002; Renault et al., 2003; Zanca et al., 2008).
Therefore, we investigated the effect of PED mutants during
CMA, on cell viability and apoptosis. To this end, we activated
CMA with serum starvation and then veriﬁed cell viability and
response to tumor necrosis factor-related apoptosis-inducing
ligand (TRAIL)-induced apoptosis in A549 cells overexpressing
either the phosphomimic or the phosphorylation-dead mutant.
Fig. 5. CMA degrades unphosphorylated PED. A: Schematic representation of the PED protein, showing phosphorylation and putative
KFEQR sites. B: HEK293 cells were transfected with cDNA for MycPED (wild-type PED), HA-PED-S104/116A (a phosphorylation-dead form
of PED), or HA-PED-S104/116D (a phosphorylated-PED mimic). After 48 h, 1mg of protein extracts were immunoprecipitated with anti-PED
or control IgG, resolved with SDSPAGE, and then Western blotted. The numbers in brackets indicate optical density of the HSC70 bands,
arbitrarily set to 1 for the Myc-PED lysate; HA-PED-S104/116D versus HA-PED-S104/11A, P-value <0.03. C: A549 cells were transfected as in B
and lysosomes inhibited with either 15mM of NH4Cl for 4 h or 10mM of chloroquine (CQ) for 24h. The numbers in brackets indicate optical
densities of the HA or Myc bands, arbitrarily set to 1 for control lanes; *P< 0.03 (vs. HA-PED-S104/116D); #P< 0.04 (versus HA-PED-S104/
116D). D: A549 cells were transfected as in B and CMA activated either by serum deprivation (SD) for 24h or overexpression of LAMP2A via
transduction with a cDNA (LAMP2A). The numbers in brackets indicate optical densities of the HA or Myc bands, arbitrarily set to 1 for
control lanes; *P< 0.04 versus HA-PED-S104/116D; #P< 0.03 versus HA-PED-S104/116D.
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We found that the phosphomimic PED mutant conferred a
growth advantage (Fig. 6A) and increased resistance to TRAIL-
induced apoptosis (Fig. 6B).
Discussion
Here, we identify PED as a new substrate of chaperone-
mediated autophagy. We identiﬁed two KFERQ-like motifs in
the amino acid sequence of PED, one of which is located within
a previously described phosphorylation site. Although it is clear
that the chaperone protein HSC70 can recognize the KFERQ
motif, little is known on how this process is modulated. Protein
folding-unfolding may be important for recognition (Kaushik
and Cuervo, 2012a), so if the KFERQ motif is present in the
protein’s core, the binding of HSC70 may occur only when the
protein unfolds. In other proteins, the motif may be masked by
protein–protein interaction. Very little is known on the effect
of post-translational modiﬁcation on the ability of HSC70 to
recognize CMA-targeting motifs. Acetylation is the only post-
translational modiﬁcation described to date to modulate CMA
of a protein (Lv et al., 2011). PED is the ﬁrst example where
phosphorylation modiﬁes the ability of HSC70 to access
KFERQ-like motifs.
PED phosphorylation occurs on two serine residues:
Ser104, a PKC target (Krueger et al., 2005), and Ser116, which
is targeted byCaMKII and AKT (Condorelli et al., 2002; Trencia
et al., 2003; Sulzmaier et al., 2012). Several reports suggest that
PED phosphorylation is determinant for its functions:
phosphorylation leads to a tumor-promoting effect through
increased proliferation and inhibition of apoptosis, whereas
dephosphorylation allows PED to bind ERK1/2, leading to a
tumor suppressing effect through blockade of nuclear
translocation and cellular proliferation (Formstecher
et al., 2001). Phosphorylation of Ser116 regulates the anti-
apoptotic function of PED and modulates its targeting to the
death-inducing signaling complex (Condorelli et al., 1999;
Trencia et al., 2003). Several ﬁndings support the idea that PED
may have a dual pro-survival/tumorigenic function in many
types of neoplasm, such as skin, breast, ovarian, and lung
cancer, and glioblastoma, while being tumor-suppressive in
other types (Lee et al., 2012; Funke et al., 2013). Thus, PED
phosphorylation status is very important for cell fate. Most
emphasis has been placed in the identiﬁcation of the kinases
that contribute to the switch from an anti- to a pro-oncogenic
function by actively phosphorylating PED. For example, PED
function is regulated by HSP27 through modulation of Akt
activity and stability (Hayashi et al., 2012). However, the
contribution of other cellular processes to the modulation of
this switch has not been previously explored. In this report, we
show for the ﬁrst time that changes in the balance of PED
phosphorylation is mediated by degradation via CMA.
We have observed that PED is up-regulated in lung cancer,
and its expression correlates with histological grade and
apoptosis resistance (Zanca et al., 2008; Incoronato
et al., 2010, 2011). PEDmight be up-regulated in cancer cells to
compensate for its faster degradation due to the up-regulation
of CMA, which recent reports have described as being up-
regulated, in particular, in lung cancer (Kon et al., 2011).
However, a more attractive explanation is that the up-
regulation of CMA observed in this type of cancer (Kon
et al., 2011) may contribute to further imbalance between the
pro- and anti-oncogenic forms of PED by removal of the subset
of PED having an inhibitory effect on tumorigenesis. Indeed, as
reported here, non-phosphorylated PED, in contrast to the
phosphorylated protein, is readily delivered for CMA
degradation (Fig. 7). Therefore, we speculate that the up-
regulation of CMA inherent in lung cancer may preferentially
degrade the tumor-suppressor form of PED, contributing in
this way to tumor progression. Further studies will aim to
elucidate whether the anti-oncogenic effect of blocking CMA in
cancer cells (Kon et al., 2011) is obtained, at least in part,
through an increase in the amount of the anti-oncogenic PED.
Although the mechanism described here mainly refers to
CMA-mediated autophagy, it is worth highlighting that PED
activates macro-autophagy in several tissues, such as ovarian
cancer cells, glioma cells, and skeletal muscle cells (Bock
et al., 2010; Iovino et al., 2012). PED phosphorylation is
important for its effect on macro-autophagy activation, since
abrogation of PED phosphorylation strongly diminished the
number of autophagic cells (Bock et al., 2010). Thus, it
interesting to speculate that in cancer, CMA mainly targets
unphosphorylated (tumor suppressive) PED, contributing in
this way to chemo- or radio-therapy resistance.
Finally, phosphorylation status may regulate the level of PED
also via other processes, such as ubiquitinylation and
proteasomal targeting. Phorbol esters (12-O-
tetradecanoylphorbol-13-acetate) increase PED expression at
the post-translational level by inducing phosphorylation at
Fig. 6. Effect of PED phosphorylation on cell growth and apoptosis. A: A549 cells were transfected with either the phosphomimic or
phosphorylation-dead mutant of PED. After 24h, cells were serum-starved and cell viability assessed with an MTT assay at different time-
points. B: A549 cells were transfected as indicated in A and after 24h were treated with SuperKiller TRAIL (50ng/ml), with or without serum
deprivation for a further 24h. Cell viability was assessed with an MTT assay. MeansþSD. *P< 0.028 versus empty vector.
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Ser116 and preventing ubiquitinylation and proteosomal
degradation (Perfetti et al., 2007). Thus, phosphorylation may
be a general mechanism for the regulation of PED level, not
only through CMA but also through the ubiquitin/proteasomal
pathway.
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